FDA Import Refusal AEK-0935613-9/90002/1 — IPCA LABORATORIES LTD
The FDA refused shipment AEK-0935613-9/90002/1 from IPCA LABORATORIES LTD (India) on Aug 13, 2026. The refused product falls under Drugs and Biologics — GLIPIZIDE (ANTI-DIABETIC). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- Aug 13, 2026
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 61PCA09 GLIPIZIDE (ANTI-DIABETIC)
- Charges
- 75